Clinical trial
Comparison of Oral and Intravenous Ibuprofen for Treatment of Patent Ductus Arteriosus in Extremely Premature Infants: A Randomized Controlled Trial
NCT01149564 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Oral and Intravenous Ibuprofen for Treatment of Patent Ductus Arteriosus in Extremely Premature Infants: A Randomized Controlled Trial
- Lead sponsor
- China Medical University Hospital
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- December 31, 2009
- Completion date
- June 30, 2012
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
extremely premature infants, iv ibuprofen, oral ibuprofen, pda